Chen, Z. (2024). Metabolic pathways and therapeutic opportunities in the chronic lymphocytic leukemia microenvironment. [Thesis, fully internal, Universiteit van Amsterdam].
Montironi, C. (2024). Metabolic interventions in chronic lymphocytic leukemia: Towards tumor elimination and immune rejuvenation. [Thesis, fully internal, Universiteit van Amsterdam].
Favaro, F. (2023). The UPR in cell death and inflammation. [Thesis, fully internal, Universiteit van Amsterdam].
Kielbassa, K. (2023). Exploring the role of Bcl-2 family members & B-cell targeted therapies: From CLL to B-IMDs. [Thesis, fully internal, Universiteit van Amsterdam].
Martens, A. W. J. (2022). Exploration of T-cell dysfunction in CLL and other B-cell malignancies: Implications for therapy. [Thesis, fully internal, Universiteit van Amsterdam].
van Bruggen, J. A. C. (2022). Discovery beyond the void: Energizing T cells in chronic lymphocytic leukemia. [Thesis, fully internal, Universiteit van Amsterdam].
Haselager, M. V. (2021). From signaling to survival: Dissecting drug resistance and proliferation in CLL. [Thesis, fully internal, Universiteit van Amsterdam].
Leeksma, A. C. (2019). Making sense of genomic complexity and nonsense-RNA in hematologic malignancies. [Thesis, fully internal, Universiteit van Amsterdam].
van Attekum, M. H. A. (2017). Formation of a tumor-supportive microenvironment in chronic lymphocytic leukemia: Addressing the reciprocal interactions in the CLL—T cell—macrophage triad. [Thesis, fully internal, Universiteit van Amsterdam].
Thijssen, R. (2016). The interplay between microenvironmental signaling and novel targeted drugs in CLL. [Thesis, fully internal, Universiteit van Amsterdam].
